Identification of AIM2 as a downstream target of JAK2V617F
{{output}}
Background: The gain-of-function mutation JAK2V617F is frequently found in Philadelphia-chromosome-negative myeloproliferative neoplasm (MPN) patients. However, the tumorigenic properties of JAK2V617F have mostly been characteriz... ...
